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Abstract
Chronic hepatitis C virus infection is a global epidemic mainly affecting Eastern Mediterranean and European Regions with 2.3% and 1.5% 
prevalence, respectively. In addition, nearly 80% of people with HIV who inject drugs also have HCV infection. Current HCV direct acting antiviral 
agents (DAA) are well tolerated and available in most western countries. However, routine limb vein puncture remains a medical barrier for 
treatment of HIV/HCV coinfection of long-term people who inject drugs (PWIDs). In fact, difficult venous access due to poor vascular health 
consecutive to years of intravenous drug injection is a common constraint. External jugular vein puncture is a simple and safe procedure, 
which can easily be performed in an ambulatory setting in patients with very poor peripheral venous capital. This technique proves useful for 
blood screening and medical follow-up of polymorbid PWIDs (HIV/HCV co infection, non-infectious hepatic disorders, cardiovascular diseases, 
metabolic disorders, etc.) However no published protocol is currently available.
This article reviews the indications of external jugular vein puncture, its’ possible complications and the advantages it can offer long-term 
PWIDs followed elsewhere in view of overcoming medical obstacles for monitoring HIV therapy, DAAs and other concomitant treatments. It also 
provides a hands-on procedure of the technique based on the expertise of the Lausanne’s addiction medicine clinic.
Keywords:  Hepatitis C Virus; Co infection; External Jugular Vein; Direct-Acting Antiviral Treatment; Vein puncture
Setting the Problem
Globally, there are 37 million people infected with HIV and 115 million 
people with hepatitis C virus (HCV). Furthermore, 71 million people 
have chronic hepatitis C infection. According to WHO regions, Eastern 
Mediterranean and European countries have the highest prevalence rates 
of chronic hepatitis C with 2.3% and 1.5% respectively [1,2].
In addition, nearly 80% of people with HIV who inject drugs also 
have HCV co infection [1,3]. Screening and further treatment of HIV 
and HCV infections presupposes frequent and large blood collections for 
evaluation of HIV antiviral treatment (ART) and direct-acting antiviral 
treatment (DAA) efficacy, as well as monitoring for systemic side-effects 
of DAA therapy including drug-drug interactions with ART and other 
co-medications [4].
A good number of licensed rapid tests are currently available for 
antibody screening of HIV and HCV using capillary blood and saliva, 
respectively [5]. However, for diagnosis confirmation and viral load 
measuring we do not dispose of standardized algorithms based on capillary 
blood draw [6]. Peripheral venous access and limb phlebotomy can be 
challenging in long-term PWIDs due to poor vascular health as a result 
of years of intravenous drug injection and related medical complications 
[7,8]. Furthermore, femoral drug injection is a common practice among 
PWIDs [9-11].
In this context optional central blood draw from external jugular 
vein (EJV) was previously assessed in PWIDs with difficult venous 
access proving to be safe with no recorded adverse events and high 
level of satisfaction among all patients [12]. EVJ puncture is a simple 
procedure, which can easily be performed in an ambulatory setting so as 
to circumvent the difficulty of obtaining large blood specimens in patients 
with very poor peripheral venous capital and allow medical follow-up 
polymorbid PWIDs (HIV and HCV infections, non-infectious hepatic 
disorders, metabolic disorders, COPD, cardiovascular disease, etc.). It 
is used on routine basis by clinicians in Lausanne’s center for addiction 
medicine in accordance to a local guideline [13].
However no published protocol is currently available. Therefore 
this article reviews the indications of external jugular vein puncture, 
its’ possible complications and the advantages it can offer long-term 
PWIDs followed elsewhere in view of overcoming medical obstacles for 
monitoring HIV therapy, DAAs and other concomitant treatments. It also 
provides a hands-on procedure of the technique based on the expertise of 
the Lausanne’s addiction medicine clinic.
Suitability of the Technique: Indications and 
Contraindications to EJV Puncture
Prior to performing an EJV blood collection, it is crucial to thoroughly 
assess the patient’s peripheral venous capital, and identify any sites suitable 
for limb vein puncture. Difficult venous access can be established using 
both patient history (multiple failed attempts at peripheral vein puncture), 
and clinical examination.
Equally crucial is to assess and address the risk of reviving drug craving 
in PWID who have previously injected their external jugulars should this 
site be chosen to draw blood samples. Check for coagulopathy and platelet 
level in the patient’s record, and if abnormal, exercise precaution so as to 
minimize the risk of prolonged bleeding.
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If no alternate suitability for blood collection from conventional 
peripheral sites is identified, proceed to bilateral EJV assessment for 
suitability for vein puncture. If the EJV is not clearly identifiable visually, 
or if there is the presence of local bruising or trauma to the neck, EJV vein 
puncture should not be attempted. Prior EJV injectors with important 
local venous scar tissue should also not undergo this procedure. Profound 
alterations in clotting or coagulation, or an agitated poorly cooperative 
patient (possibly under influence of psychoactive substances) are also 
general (yet relative) contra-indications to performing EJV blood collection.
Advantages of the Technique
•	 Drawing blood samples from central veins as EJV presents no 
additional pain to the patient [12].
•	 The EJV is a superficial vein, with little risk of provoking lesions 
to profound structures when collecting blood from it - unlike 
attempts to access the internal jugular which can be complicated by 
a pneumothorax for example.
•	 The neck is a fairly “clean” site for blood sampling, unlike the groin, 
and may thus limit the risk of infectious complications related to 
blood sampling [14].
•	 There is no adjacent artery to the EJV such as there is in the groin, 
which reduces the risk of arterial puncture and the associated 
complication of a compressive hematoma [14]. This consideration 
is especially relevant in patients who may have concurrent 
coagulopathy or thrombocytopenia as a result of HCV-related liver 
disease, HCV-treatment, alcohol misuse, etc.
•	 In the case of patients who have particularly difficult peripheral 
venous access, EJV vein puncture presents an important risk-
reduction strategy for blood collectors due to the reduction in the 
number of vein puncture attempts necessary to collect blood.
•	 The EJV is a superficial vein which presents a relatively large caliber 
in comparison with peripheral limb veins, and thus the decent 




The external jugular vein is a superficial vein situated on the lateral 
portion of the neck. It is easily identified visually, and runs obliquely from 
the angle of the mandible down to the middle of the clavicle. Its’ diameter 
is roughly 5-10mm, but varies widely from one side to the other, between 
individuals, and seems inversely correlated to the diameter of the internal 
jugular vein on the ipsilateral side [15] as shown in Figure 1.
Preparation and positioning of the patient
•	 Clearly explain the procedure to the patient to obtain his informed 
consent, and reduce any anxiety.
•	 Inform the patient about risks incurred through EJV drug injection, 
thus limiting the temptation for ulterior use of this venous route 
of access.
•	 Make sure the patient is fully supine, with the head lying flat. 
Examine both left and the right neck sides to visually explore both 
EJVs. A slight Trendelenburg position if the examination table so 
allows, or asking the patient to perform a Valsalva maneuver can help 
to better identify the EJV by visualization and palpation (Figure 2a).
EJV Blood collection step-by-step
•	 Use an adequately equipped area to perform the procedure, so as to 
ensure patient security and reduce infectious risks.
•	 Wash and/or disinfect hands, and wear gloves.
•	 Ask the patient to lay down supine on his back, and to rotate his 
head to the side. The patient’s head must lie in a relatively neutral 
position, neither extended nor flexed, as this could mask the EJV. 
Make sure the patient is in a comfortable position.
•	 Ask the patient to perform a Valsalva manoeuver so as to distend the 
EJV (Figure 2a).
•	 If the EJV proves difficult to visually identify, slightly lower the head 
by elevating the neck by propping the shoulders up with a pillow 
(Figure 2b). 
•	 Clean the skin superficial to the EJV with cutaneous disinfectant. 
Allow the skin to dry.
•	 Place a finger on the EJV on its’ distal portion towards the clavicle.
•	 Gently introduce the butterfly needle (22 G or 21 G) in the EJV 
following its direction.
•	 Once the butterfly is introduced in the EJV lumen, reassure the 
patient by inviting him/her to breathe normally if the Valsalva 
maneuver is still being performed.
•	 Attach the vacutainer adaptor to the butterfly needle, and collect 
blood samples as needed.
•	 Withdraw the butterfly needle and apply some pressure to the site 
of vein puncture during 3-5 minutes to minimize the risk of ulterior 
bleeding.
•	 Avoid multiple vein puncture attempts to the EJV to preserve the 
vein from damage, and avoid excessive discomfort to the patient.
Figure 1: External jugular vein is a superficial vein situated on the lateral portion of the neck
Source: http://emedicine.medscape.com/article/80317-overview#a15
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Post-procedural precautions and recommendations
•	 Help the patient to resume a seated position, and inform the patient 
of the possibility of feeling slightly dizzy. As for any other vein 
puncture, a vaso-vagal reaction is possible.
Summary
EJV blood sampling is an easily and safely performed bedside technique 
which can prove useful in the clinical management of patients with poor 
peripheral venous capital, thus affording them the blood work required to 
treat them optimally.
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Figure 2: a) Lateral Supine Head Position
b) Optional Positioning of Patient to Better Visualize EJV
